Variant report

Variant	nsv976671
Chromosome Location	chr12:123874923-123875423
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:51)
CpG islands
(count:0)
Chromatin interactive
region (count:19)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:51 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr12:123874860-123875010	HMEC	breast:	n/a	n/a
2	CTCF	chr12:123875220-123875370	HAc	cerebellar:	n/a	n/a
3	CTCF	chr12:123875220-123875370	HRE	kidney:	n/a	n/a
4	CTCF	chr12:123875160-123875310	AG10803	skin:	n/a	n/a
5	CTCF	chr12:123875120-123875270	HEEpiC	esophagus:	n/a	n/a
6	CTCF	chr12:123875020-123875170	HAc	cerebellar:	n/a	n/a
7	CTCF	chr12:123875240-123875390	NB4	blood:	n/a	n/a
8	CTCF	chr12:123875040-123875190	HCPEpiC	choroid plexus:	n/a	n/a
9	CTCF	chr12:123875160-123875310	HUVEC	blood vessel:	n/a	n/a
10	CTCF	chr12:123874820-123874970	SAEC	small airway:	n/a	n/a
11	CTCF	chr12:123875251-123875268	HUVEC	blood vessel:	n/a	n/a
12	CTCF	chr12:123875120-123875270	HCPEpiC	choroid plexus:	n/a	n/a
13	CTCF	chr12:123875140-123875290	AG10803	skin:	n/a	n/a
14	CTCF	chr12:123875120-123875270	HRE	kidney:	n/a	n/a
15	CTCF	chr12:123875300-123875450	HFF-Myc	foreskin:	n/a	n/a
16	CTCF	chr12:123875180-123875330	HBMEC	blood vessel:	n/a	n/a
17	CTCF	chr12:123874880-123875030	HUVEC	blood vessel:	n/a	n/a
18	CTCF	chr12:123875180-123875330	BJ	skin:	n/a	n/a
19	CTCF	chr12:123875080-123875230	HFF	foreskin:	n/a	n/a
20	CTCF	chr12:123875180-123875330	AG04449	skin:	n/a	n/a
21	CTCF	chr12:123875120-123875270	HPAF	blood vessel:	n/a	n/a
22	CTCF	chr12:123875120-123875270	HUVEC	blood vessel:	n/a	n/a
23	CTCF	chr12:123875000-123875150	HRPEpiC	eye:	n/a	n/a
24	CTCF	chr12:123875200-123875350	AG04449	skin:	n/a	n/a
25	HA-E2F1	chr12:123874121-123874988	MCF-7	breast:	n/a	chr12:123874358-123874368
26	MAX	chr12:123874066-123875039	MCF-7	breast:	n/a	chr12:123874490-123874499
27	MAZ	chr12:123872947-123875108	IMR90	lung:	n/a	chr12:123874490-123874499
28	MXI1	chr12:123872542-123875203	SK-N-SH	brain:	n/a	n/a
29	MXI1	chr12:123872709-123875094	IMR90	lung:	n/a	n/a
30	MYC	chr12:123875198-123875293	HUVEC	blood vessel:	n/a	n/a
31	NR2F2	chr12:123874289-123875121	MCF-7	breast:	n/a	chr12:123874378-123874393
32	POLR2A	chr12:123874051-123875076	ECC-1	luminal epithelium:	n/a	n/a
33	POLR2A	chr12:123874824-123875875	HUVEC	blood vessel:	n/a	n/a
34	POLR2A	chr12:123874157-123875850	HUVEC	blood vessel:	n/a	n/a
35	POLR2A	chr12:123875290-123875377	GM12878	blood:	n/a	n/a
36	POLR2A	chr12:123874217-123874977	MCF-7	breast:	n/a	n/a
37	POLR2A	chr12:123874692-123874971	ProgFib	skin:	n/a	n/a
38	POLR2A	chr12:123875389-123875558	HepG2	liver:	n/a	n/a
39	POLR2A	chr12:123871971-123875084	K562	blood:	n/a	n/a
40	POLR2A	chr12:123874909-123875430	HUVEC	blood vessel:	n/a	n/a
41	POLR2A	chr12:123875379-123875450	GM12878	blood:	n/a	n/a
42	POLR2A	chr12:123874759-123875158	K562	blood:	n/a	n/a
43	POLR2A	chr12:123874144-123875154	K562	blood:	n/a	n/a
44	POLR2A	chr12:123874101-123875208	GM12878	blood:	n/a	n/a
45	POLR2A	chr12:123874056-123875176	SK-N-MC	brain:	n/a	n/a
46	POLR2A	chr12:123874621-123874936	GM12878	blood:	n/a	n/a
47	POLR2A	chr12:123874116-123875878	HUVEC	blood vessel:	n/a	n/a
48	SIN3A	chr12:123874101-123874942	H1-hESC	embryonic stem cell:	n/a	chr12:123874340-123874353
49	SIN3AK20	chr12:123874119-123875194	MCF-7	breast:	n/a	n/a
50	SPI1	chr12:123875420-123875856	HL-60	blood:	n/a	n/a

No data

(count:19 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:123872416..123876102-chr12:124017252..124019601,4	MCF-7	breast:
2	chr12:123754082..123756520-chr12:123873506..123875645,3	K562	blood:
3	chr12:123873866..123876385-chr12:123942538..123944226,2	MCF-7	breast:
4	chr12:123872056..123874942-chr12:124085224..124088307,3	MCF-7	breast:
5	chr12:123872223..123875553-chr12:124085591..124088201,3	MCF-7	breast:
6	chr12:123845591..123852236-chr12:123866929..123875043,19	MCF-7	breast:
7	chr12:123847204..123849398-chr12:123874460..123876425,2	K562	blood:
8	chr12:123873719..123876506-chr12:124067448..124069174,2	K562	blood:
9	chr12:123872355..123875545-chr12:123919640..123922793,3	MCF-7	breast:
10	chr12:123872778..123876196-chr12:124065295..124071344,6	MCF-7	breast:
11	chr12:123873193..123874940-chr12:123942406..123944140,2	K562	blood:
12	chr12:123753349..123756927-chr12:123873006..123875020,4	MCF-7	breast:
13	chr12:123871385..123875741-chr12:124017374..124019532,6	MCF-7	breast:
14	chr12:123870366..123875219-chr12:124064500..124069174,6	K562	blood:
15	chr12:123753478..123757222-chr12:123871925..123875006,5	K562	blood:
16	chr12:123715746..123718967-chr12:123870796..123875270,4	K562	blood:
17	chr12:123874611..123876401-chr12:123967217..123969868,2	K562	blood:
18	chr12:123845329..123854937-chr12:123865496..123876607,58	K562	blood:
19	chr12:123847748..123850760-chr12:123875045..123877875,5	MCF-7	breast:

No data

Variant related genes	Relation type
SETD8	TF binding region
ENSG00000139697	chromatin interactions
ENSG00000130921	chromatin interactions
ENSG00000188026	chromatin interactions
ENSG00000256092	chromatin interactions
ENSG00000051825	chromatin interactions
ENSG00000247373	chromatin interactions
ENSG00000086598	chromatin interactions
ENSG00000111364	chromatin interactions
ENSG00000184209	chromatin interactions
ENSG00000111328	chromatin interactions
ENSG00000150977	chromatin interactions

Extended variants
information (count: 31 )
Associated
traits (count: 70 )

Variant overlapped rSNPs/rCNVs (count:31 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs76801833	chr12:123874937-123874938	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
2	rs561567780	chr12:123875015-123875016	Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
3	rs192853976	chr12:123875037-123875038	Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
4	rs546919382	chr12:123875038-123875039	Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
5	rs201708111	chr12:123875107-123875108	Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
6	rs532633882	chr12:123875110-123875111	Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
7	rs550573271	chr12:123875112-123875113	Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
8	rs200055909	chr12:123875146-123875147	Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
9	rs371538177	chr12:123875155-123875156	Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
10	rs202048118	chr12:123875223-123875224	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
11	rs536801776	chr12:123875246-123875247	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
12	rs146638825	chr12:123875251-123875252	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
13	rs567488801	chr12:123875266-123875267	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
14	rs534833970	chr12:123875268-123875269	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
15	rs116106163	chr12:123875270-123875271	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	12 gene(s)	Overlapped CNVs	n/a
16	rs187714652	chr12:123875281-123875282	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
17	rs538887430	chr12:123875295-123875296	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
18	rs74356260	chr12:123875311-123875312	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
19	rs373776406	chr12:123875320-123875321	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
20	rs116638108	chr12:123875330-123875331	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
21	rs374479813	chr12:123875339-123875340	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
22	rs368402370	chr12:123875348-123875349	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
23	rs371873771	chr12:123875371-123875372	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
24	rs192520202	chr12:123875372-123875373	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
25	rs201980614	chr12:123875373-123875374	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
26	rs368011076	chr12:123875374-123875375	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
27	rs183765259	chr12:123875380-123875381	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
28	rs572869728	chr12:123875389-123875390	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
29	rs28660993	chr12:123875394-123875395	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	10 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
30	rs565098773	chr12:123875410-123875411	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
31	rs201507402	chr12:123875417-123875418	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:70)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	21390271	CNVD
Cancer	20164919	CNVD
Cancer	16751803	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Wilms tumour	21544195	CNVD
Ovarian cancer	21720365	CNVD
Colorectal cancer	16272173	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	16397240	CNVD
Breast cancer	17133270	CNVD
Breast cancer	17603634	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Schizophrenia	18923514	CNVD
Schizophrenia	22241247	CNVD
Cryptorchidism	21048976	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Neuroblastoma	18923191	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21806811	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Beckwith-Wiedemann syndrome	20648245	CNVD
Developmental delay	21457577	CNVD
dysmorphic	21457577	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chordoma	18071362	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:267 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:123872800-123875000	Active TSS	H9 Cell Line	embryonic stem cell
2	chr12:123872800-123875000	Active TSS	Pancreatic Islets	Pancreatic Islet
3	chr12:123873000-123875000	Active TSS	Brain Hippocampus Middle	brain
4	chr12:123873000-123875000	Active TSS	Gastric	stomach
5	chr12:123873000-123875000	Active TSS	Lung	lung
6	chr12:123873000-123875000	Active TSS	Small Intestine	intestine
7	chr12:123873000-123875000	Active TSS	HSMM	muscle
8	chr12:123873000-123875200	Active TSS	Left Ventricle	heart
9	chr12:123873000-123875200	Active TSS	HSMMtube	muscle
10	chr12:123873000-123875400	Active TSS	Esophagus	oesophagus
11	chr12:123873200-123875000	Active TSS	Right Ventricle	heart
12	chr12:123873200-123875400	Active TSS	Aorta	Aorta
13	chr12:123874000-123875000	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
14	chr12:123874000-123875000	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
15	chr12:123874000-123875400	Flanking Active TSS	Primary hematopoietic stem cells	blood
16	chr12:123874200-123875000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
17	chr12:123874200-123875000	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
18	chr12:123874200-123875000	Active TSS	Fetal Kidney	kidney
19	chr12:123874200-123875000	Flanking Active TSS	Placenta	Placenta
20	chr12:123874200-123875200	Transcr. at gene 5' and 3'	IMR90 fetal lung fibroblasts Cell Line	lung
21	chr12:123874200-123875200	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
22	chr12:123874200-123875200	Flanking Active TSS	Primary T cells fromperipheralblood	blood
23	chr12:123874200-123875200	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
24	chr12:123874200-123875400	Flanking Active TSS	Primary B cells from cord blood	blood
25	chr12:123874200-123875400	Enhancers	Primary T helper naive cells from peripheral blood	blood
26	chr12:123874200-123875600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
27	chr12:123874200-123875600	Transcr. at gene 5' and 3'	Foreskin Keratinocyte Primary Cells skin03	Skin
28	chr12:123874200-123876000	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
29	chr12:123874200-123876200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
30	chr12:123874200-123876800	Transcr. at gene 5' and 3'	Foreskin Fibroblast Primary Cells skin02	Skin
31	chr12:123874400-123875000	Transcr. at gene 5' and 3'	H9 Derived Neuron Cultured Cells	ES cell derived
32	chr12:123874400-123875000	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
33	chr12:123874400-123875000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
34	chr12:123874400-123875000	Flanking Active TSS	Brain Cingulate Gyrus	brain
35	chr12:123874400-123875000	Flanking Active TSS	Colonic Mucosa	Colon
36	chr12:123874400-123875000	Enhancers	Fetal Brain Male	brain
37	chr12:123874400-123875000	Flanking Active TSS	Fetal Brain Female	brain
38	chr12:123874400-123875000	Flanking Active TSS	Fetal Muscle Leg	muscle
39	chr12:123874400-123875000	Transcr. at gene 5' and 3'	Dnd41	blood
40	chr12:123874400-123875200	Flanking Active TSS	Adipose Nuclei	Adipose
41	chr12:123874400-123875200	Flanking Active TSS	Brain Germinal Matrix	brain
42	chr12:123874400-123875200	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
43	chr12:123874400-123875200	Flanking Active TSS	Stomach Smooth Muscle	stomach
44	chr12:123874400-123875400	Transcr. at gene 5' and 3'	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
45	chr12:123874400-123875400	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
46	chr12:123874400-123875400	Flanking Active TSS	Brain Anterior Caudate	brain
47	chr12:123874400-123875600	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
48	chr12:123874400-123875600	Transcr. at gene 5' and 3'	NHEK	skin
49	chr12:123874400-123875800	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
50	chr12:123874400-123875800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links